Schonfeld Strategic Advisors LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2023$65,280
-89.2%
27,200
-47.1%
0.00%
-100.0%
Q4 2022$607,034
-11.0%
51,400
+678.8%
0.01%
-61.5%
Q3 2020$682,000
+40.6%
6,600
-21.2%
0.01%
-58.1%
Q1 2020$485,000
-63.1%
8,376
-69.2%
0.03%
-32.6%
Q2 2019$1,315,000
+117.4%
27,200
+126.7%
0.05%
+39.4%
Q2 2018$605,000
+91.5%
12,000
+100.3%
0.03%
+37.5%
Q1 2018$316,0005,9910.02%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders